Lena von Koch Selected Research

Activities of Daily Living (ADL)

12/2022	Depression symptoms 6 years after stroke are associated with higher perceived impact of stroke, limitations in ADL and restricted participation.
2/2022	Activities in Daily Living: The development of a new client-centred ADL intervention for persons with stroke.
12/2019	Experiences of participating in a client-centred ADL intervention after stroke.
2/2019	Five-year follow-up of a cluster-randomized controlled trial of a client-centred activities of daily living intervention for people with stroke.
1/2018	Prestroke Mobility and Dementia as Predictors of Stroke Outcomes in Patients Over 65 Years of Age: A Cohort Study From The Swedish Dementia and Stroke Registries.
1/2018	Resource use of healthcare services 1 year after stroke: a secondary analysis of a cluster-randomised controlled trial of a client-centred activities of daily living intervention.
1/2018	A feasibility study of a mobile phone supported family-centred ADL intervention, F@ce™, after stroke in Uganda.
1/2017	A 9-year follow-up of a self-management group intervention for persistent neck pain in primary health care: a randomized controlled trial.
8/2016	A cluster randomized controlled trial of a client-centred, activities of daily living intervention for people with stroke: one year follow-up of caregivers.
1/2016	Client-centred ADL intervention after stroke: Occupational therapists' experiences.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lena von Koch Research Topics

Disease

34	Stroke (Strokes) 12/2022 - 01/2003
6	Dementia (Dementias) 10/2021 - 09/2014
5	Pain (Aches) 10/2021 - 01/2003
4	Neck Pain (Cervicalgia) 01/2017 - 03/2006
2	Multiple Sclerosis 05/2012 - 06/2007
1	Ischemic Stroke 03/2022
1	Fatigue 07/2008
1	Kinesiophobia 03/2006
1	Aphasia (Dysphasia) 02/2005

Drug/Important Bio-Agent (IBA)

4	Analgesics (Analgesic Drugs)IBA 01/2017 - 03/2006
2	2-toluenesulfonamide (OTS)IBA 01/2021 - 01/2016
2	Dihydrotachysterol (AT 10)IBA 12/2011 - 07/2010
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 12/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2021
1	Memantine (Namenda)FDA Link 10/2021
1	Pharmaceutical PreparationsIBA 01/2021

Therapy/Procedure

25	Activities of Daily Living (ADL) 12/2022 - 02/2005
3	Length of Stay 05/2022 - 01/2003
3	Stroke Rehabilitation 01/2020 - 06/2015
3	Patient Care 02/2019 - 09/2014
2	Ambulatory Care (Outpatient Care) 05/2022 - 11/2020
2	Secondary Prevention 03/2022 - 12/2019
2	Patient Transfer (Patient Dumping) 12/2021 - 12/2020
2	Physical Therapy Modalities (Physical Therapy Technique) 12/2011 - 07/2010
1	Continuity of Patient Care 05/2022
1	Drug Prescriptions 10/2021
1	Neurological Rehabilitation 12/2020
1	Institutionalization (Institutionalized Persons) 01/2020
1	Bed Rest (Bedrest) 04/2018
1	Occupational Therapy (Therapy, Occupational) 01/2018
1	Home Nursing (Nursing, Home) 01/2018
1	Early Ambulation 01/2017
1	Therapeutics 01/2017
1	Medical Day Care (Partial Hospitalization) 09/2013